| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/24/2003 | EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 09/24/2003 | EP1345620A2 Stable enzymatic wound debrider |
| 09/24/2003 | EP1345614A1 IMPROVED AND STABLE EXTRACT FROM i HYPERICUM PERFORATUM L. /i , METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A TOPICAL MEDICAMENT |
| 09/24/2003 | EP1345613A2 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 09/24/2003 | EP1345611A1 An antibiotic/analgesic formulation and a method of making this formulation |
| 09/24/2003 | EP1345610A1 Method of treatment |
| 09/24/2003 | EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/24/2003 | EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/24/2003 | EP1345597A2 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
| 09/24/2003 | EP1345595A1 Ion-strength independent sustained release pharmaceutical formulation |
| 09/24/2003 | EP1345594A1 Thermoformable solid pharmaceutical composition for controlled release of ivabradine |
| 09/24/2003 | EP1345593A2 Lipid microparticles by cryogenic micronization |
| 09/24/2003 | EP1345592A2 Rapidly dispersing pharmaceutical composition comprising effervescent agents |
| 09/24/2003 | EP1345591A1 Pharmaceutical aerosol formulation |
| 09/24/2003 | EP1345590A1 Micellar colloidal pharmaceutical compositions containing a lipophilic active principle |
| 09/24/2003 | EP1345589A1 Solvent systems for pharmaceutical agents |
| 09/24/2003 | EP1345588A2 Sustained release drug delivery devices |
| 09/24/2003 | EP1345587A1 Ionophore antibiotic formulations |
| 09/24/2003 | EP1345585A1 Compositions for prevention and alleviation of skin wrinkles |
| 09/24/2003 | EP1345568A2 Stable skin conditioning compositions containing retinoid boosters |
| 09/24/2003 | EP1345549A1 Dispensing device |
| 09/24/2003 | EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 09/24/2003 | EP1345488A1 Apparatus and method for delivering a beneficial agent |
| 09/24/2003 | EP1251741B1 Delivering substances to invertebrate organisms |
| 09/24/2003 | EP1200065B1 Intravaginal clindamycin ovule composition |
| 09/24/2003 | EP1181302B1 Orally active a1 adenosine receptor agonists |
| 09/24/2003 | EP1181190B1 Method and apparatus for loading a container with a product |
| 09/24/2003 | EP1165558B1 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/24/2003 | EP1133322B1 Improved uncomplexed cyclodextrin compositions for odor control |
| 09/24/2003 | EP1085856B1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 09/24/2003 | EP0999828B1 Method for producing active agent preparations with controlled release from a matrix |
| 09/24/2003 | EP0969871B1 Method for the production of homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances |
| 09/24/2003 | EP0938345B1 Aqueous-based pharmaceutical composition |
| 09/24/2003 | EP0930880B1 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid |
| 09/24/2003 | EP0918509B1 Biocompatible devices with foam scaffolds |
| 09/24/2003 | EP0858342B1 Dry compositions of ionophore antibiotics |
| 09/24/2003 | EP0785713B1 Creating an aerosolized formulation of insulin |
| 09/24/2003 | EP0741550B1 Multiple layer alginate coatings of biological tissue for transplantation |
| 09/24/2003 | CN1444489A Aerosol container for formulations of salmeterol xinafoate |
| 09/24/2003 | CN1444488A Use and improvement of honey in wound dressings |
| 09/24/2003 | CN1444485A Rapidly-disintegrating tablets for animals |
| 09/24/2003 | CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor |
| 09/24/2003 | CN1444482A Pharmaceutical compositions containing tobramycin and xanthan gum |
| 09/24/2003 | CN1444480A Highly absorbable solid preparation |
| 09/24/2003 | CN1444478A Use of celecoxib composition for fast pain relief |
| 09/24/2003 | CN1444474A Nonoral preparation having three-layer structure |
| 09/24/2003 | CN1444473A Composition and drug form for curing oral nosomycosis |
| 09/24/2003 | CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex |
| 09/24/2003 | CN1444450A Allantoin-containing skin cream |
| 09/24/2003 | CN1443573A Recombinant human interferon alpha 2 b nose drops and its production method |
| 09/24/2003 | CN1443572A Recombinant human interferon alpha 2 b lozenge and its production method |
| 09/24/2003 | CN1443571A Bone growth factor injection and its preparation method |
| 09/24/2003 | CN1443558A Preparation method of Bingling ointment for curing burn and scald |
| 09/24/2003 | CN1443555A Medicine plaster for curing laryngopharyngitis and its preparation method |
| 09/24/2003 | CN1443553A Bagged Chinese medicine pieces prepared for decoction and its preparation method |
| 09/24/2003 | CN1443535A Tegasevod maleate oral preparation and its preparation process-for curing intestinal irritability syndrome |
| 09/24/2003 | CN1443534A Production method of coated vitamin C preparation used in animal feed |
| 09/24/2003 | CN1443532A Flurbiprofenbab preparation and its preparation method |
| 09/24/2003 | CN1443531A Oral cavity adhesive plaster composition for curing gingival disease, laryngopharyngitis and halitosis |
| 09/24/2003 | CN1122104C Effervescent carragheenin tablet as clarifier for barley juice of beer |
| 09/24/2003 | CN1121923C Laser borer for high speed osmotic pump |
| 09/24/2003 | CN1121899C Method for microencapsulating solid substance |
| 09/24/2003 | CN1121875C Pharmaceutical compositions for freeze drying |
| 09/24/2003 | CN1121869C Zhengtang capsule |
| 09/24/2003 | CN1121865C Oral liquid for treating piles |
| 09/24/2003 | CN1121860C Antifungal composition with enhanced bioavailability |
| 09/24/2003 | CN1121854C Trnasdermal device containing polyvinylpyrrolidone as solubility accelerator |
| 09/24/2003 | CN1121853C Pharmaceutical compositions for hardly soluble active substances |
| 09/23/2003 | US6624210 (Meth)acrylate ester copolymer with (meth)acrylate containing tertiary amine group, plasticizer, and emulsifier; powders, pastes, aqueous suspension; encapsulation; drug delivery |
| 09/23/2003 | US6624203 Nucleotide, a nucleoside or a purine or pyrimidine base; 0. 00001 to about 0.05 percent by weight a cationic, polymeric preservative display an effective preservative capacity, and an increased capacity over state-of-the-art preservative |
| 09/23/2003 | US6624200 Deliver of testosterone to the bloodstream of a mammal through a mucosal surface with polycarbophil and carbopol polymers |
| 09/23/2003 | US6624198 A prophylactic spermicidal lubricant composition and method for its use in safe sexual relations, including prevention of infection by HIV and other viruses. The composition contains:friction reducing lubricants and cosmetics |
| 09/23/2003 | US6624193 Preventive and therapeutic agents for eye diseases |
| 09/23/2003 | US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and |
| 09/23/2003 | US6624170 Method for treating cancer with water-insoluble S-Camptothecin of the closed lactone ring form and derivatives thereof |
| 09/23/2003 | US6624169 Urokinase inhibitors |
| 09/23/2003 | US6623785 Pharmaceutical dispensing apparatus and method |
| 09/23/2003 | US6623765 Microemulsion and micelle systems for solubilizing drugs |
| 09/23/2003 | US6623764 Biodegradable targetable microparticle delivery system |
| 09/23/2003 | US6623763 Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism |
| 09/23/2003 | US6623762 Simple non-toxic system, deliverable by syringe or needle-free systems, is inexpensive and reliable and aids in parenteral drug delivery or mass immunization campaigns by reducing need for repeated injections |
| 09/23/2003 | US6623761 Emulsion; therapy, diagnosis |
| 09/23/2003 | US6623760 Micronization with intermittent curing crystallization; controlled particle size distribution and amorphous content materials |
| 09/23/2003 | US6623759 A core which contains an active selected from Omeprazole, Lansoprazole and Pantoprazole, together with adjuvants, an intermediate reactive layer applied on the core, a gastric juice resistant alkali neutralized polymeric outer layer |
| 09/23/2003 | US6623758 Controlled release synergistic treatment of bacterial infections |
| 09/23/2003 | US6623757 Mixture of antibiotics; variations of releasing profiles |
| 09/23/2003 | US6623756 Directly compressed solid dosage articles |
| 09/23/2003 | US6623755 Pharmaceutical tablets |
| 09/23/2003 | US6623754 Comprises granulated rheology modifying polymers (modified acrylic acid-methacrylic acid homopolymers/copolymers) for making tablets by direct compression, without granulation first; bioavailability |
| 09/23/2003 | US6623753 Allylamine-containing liposomes |
| 09/23/2003 | US6623752 Polyacrylate matrix containing vitamin E component permeation promoter |
| 09/23/2003 | US6623751 Mixture of gellan gum and other hydrocolloid |
| 09/23/2003 | US6623746 Rapid, uniform penetration of recycled fibers; phase inversion temperature (PIT) material containing fatty esters and alcohols, fatty alcohol modified polyether and fatty acid partial glycerides; biodegradable |
| 09/23/2003 | US6623739 Oil-in-water emulsions containing metabolizable oil and alpha tocopherol; enhancing immune responses to given antigen |
| 09/23/2003 | US6623734 Super absorption coenzyme Q10 |
| 09/23/2003 | US6623732 Active polypeptide, taurine and hyaluronic acid; nonirrating |
| 09/23/2003 | US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis |
| 09/23/2003 | US6623723 Method for treating bronchial constriction and bronchospasm |
| 09/23/2003 | US6623722 Ultrasound echogenic contrast agents; higher yield; narrower size distribution; thinner shells; using such as ethanol in aqueous spray solution |
| 09/23/2003 | US6623671 Liposome extrusion process |